Literature DB >> 21308795

Hypocretin1/OrexinA-containing axons innervate locus coeruleus neurons that project to the Rat medial prefrontal cortex. Implication in the sleep-wakefulness cycle and cortical activation.

Esther Del Cid-Pellitero1, Miguel Garzón.   

Abstract

The Hypocretin1/OrexinA (Hcrt1/OxA) neuropeptides are found in a group of posterolateral hypothalamus neurons and are involved in sleep-wakefulness cycle regulation. Hcrt1/OxA neurons project widely to brainstem aminergic structures, such as the locus coeruleus (LC), which are involved in maintenance of wakefulness and EEG activation through intense projections to the medial prefrontal cortex (mPFC). Moreover, defects of the Hcrt1/OxA system are linked to narcolepsy, a disorder characterized by excessive diurnal hypersomnia and REM state disturbance. We aimed to determine whether Hcrt1/OxA neurons innervate LC neurons (noradrenergic and nonnoradrenergic) that project to the mPFC, thereby sustaining behavioral wakefulness. To assess this, we used retrograde tracing from mPFC injections and either Hcrt1/OxA or tyrosine hydroxylase (TH) immunohistochemical labeling in single sections of rat LC. The retrograde tracer Fluorogold (FG) was microinjected into mPFC and, at optimal survival periods, sections through the LC were processed for dual immunolabeling of anti-FG and either anti-Hcrt1/OxA or anti-TH antisera. Many LC neurons projecting to mPFC were nonnoradrenergic. Electron microscopy revealed a prominent localization of Hcrt1/OxA in unmyelinated axons and axon boutons (varicosities and axon terminals) within the LC. Hcrt1/OxA-immunoreactive axon boutons frequently apposed (104/1907) or made asymmetric excitatory-type synapses (60/1907) with FG-immunolabeled dendrites, indicating that Hcrt1/OxA can modulate the activity of LC neurons with cortical projections. Our results show that Hcrt1/OxA hypothalamic neurons likely excite LC neurons that project to the mPFC, and thus activate EEG and facilitate wakefulness. In narcoleptics, who are deficient in Hcrt1/OxA, impairment of this Hcrt1/OxA hypothalamic input to LC might contribute to the appearance of excessive daytime sleepiness.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21308795     DOI: 10.1002/syn.20912

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

1.  Forebrain GABAergic projections to locus coeruleus in mouse.

Authors:  Eugene L Dimitrov; Yuchio Yanagawa; Ted B Usdin
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

2.  Sympathetic nerve activity and neuro-inflammation: Who is in the driver's seat?

Authors:  S Mukerjee; E Lazartigues
Journal:  Acta Physiol (Oxf)       Date:  2017-12-20       Impact factor: 6.311

3.  Region-Specific Dissociation between Cortical Noradrenaline Levels and the Sleep/Wake Cycle.

Authors:  Michele Bellesi; Giulio Tononi; Chiara Cirelli; Pier Andrea Serra
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

4.  Orexinergic system in the locus coeruleus modulates the CO2 ventilatory response.

Authors:  Mariane C Vicente; Mirela B Dias; Elisa M Fonseca; Kênia C Bícego; Luciane H Gargaglioni
Journal:  Pflugers Arch       Date:  2016-02-01       Impact factor: 3.657

5.  Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle.

Authors:  Silvia Tortorella; Margarita L Rodrigo-Angulo; Angel Núñez; Miguel Garzón
Journal:  Front Neurosci       Date:  2013-11-19       Impact factor: 4.677

Review 6.  Orexin receptor antagonists as therapeutic agents for insomnia.

Authors:  Ana C Equihua; Alberto K De La Herrán-Arita; Rene Drucker-Colin
Journal:  Front Pharmacol       Date:  2013-12-25       Impact factor: 5.810

7.  LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy.

Authors:  Thomas E Fitch; Mark J Benvenga; Cynthia D Jesudason; Charity Zink; Amy B Vandergriff; Michelle M Menezes; Douglas A Schober; Linda M Rorick-Kehn
Journal:  Front Neurosci       Date:  2014-01-28       Impact factor: 4.677

8.  Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.

Authors:  Alexander Heifetz; Oliver Barker; G Benjamin Morris; Richard J Law; Mark Slack; Philip C Biggin
Journal:  Biochemistry       Date:  2013-11-08       Impact factor: 3.162

9.  Hypocretin1/orexinA-immunoreactive axons form few synaptic contacts on rat ventral tegmental area neurons that project to the medial prefrontal cortex.

Authors:  Esther Del Cid-Pellitero; Miguel Garzón
Journal:  BMC Neurosci       Date:  2014-09-07       Impact factor: 3.288

Review 10.  Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis.

Authors:  Antonietta Messina; Carolina De Fusco; Vincenzo Monda; Maria Esposito; Fiorenzo Moscatelli; Anna Valenzano; Marco Carotenuto; Emanuela Viggiano; Sergio Chieffi; Vincenzo De Luca; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina
Journal:  Front Neural Circuits       Date:  2016-08-25       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.